CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • CRI’s Answer to Cancer

    Just after dawn on Saturday, June 25, more than 200 cyclists began to gather in Highland Falls,…

    July 1, 2016| Katherine McCluskey
  • Immunotherapy 101? Ask a Scientist

    As part of Cancer Immunotherapy Month, Dr. Jeffrey Weber answers pressing questions from patients about cancer immunotherapy.

    June 29, 2016| CRI Staff
  • A “White Out” at the NBC TODAY Show Plaza

    On Monday, June 20, the Cancer Research Institute visited the NBC TODAY Show Plaza to raise public…

    June 20, 2016| Katherine McCluskey
  • ASCO 2016 Update: Tapping into the Potential of Anti-Tumor T Cells

    Adoptive T cell therapies provide success against some cancers, hope for several others.

    June 17, 2016| Arthur N. Brodsky, PhD
  • Together, we can #WhiteOutCancer!

    This year we’re on a mission to White Out Cancer—and we need your help!

    June 16, 2016| Katherine McCluskey
  • ASCO 2016 Update: Immunotherapy & Melanoma: The Path to Progress

    Improved approaches for treating patients with melanoma.

    June 16, 2016| Arthur N. Brodsky, PhD
  • ASCO 2016 Update: Immunotherapy’s Impact in Head & Neck Cancers

    Immunotherapy approaches provide improvements for patients with head and neck cancer.

    June 16, 2016| Arthur N. Brodsky, PhD
  • What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2016

    Hear from CRI's panel of immunotherapy experts—Drs. Andrew Sikora, Leena Gandhi, and Michel Sadelain—on what patients should…

    June 9, 2016| CRI Staff
  • ASCO 2016 Update: Beyond Checkpoint Blockade: Novel Immunotherapy Strategies for Solid Cancers

    New strategies use alternative ways to promote anti-cancer immunity.

    June 7, 2016| Arthur N. Brodsky, PhD
Previous Page
1 … 69 70 71 72 73 … 92
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute